Clinical trial
A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli
NCT07338123 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli
- Lead sponsor
- Chinese PLA General Hospital
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- August 31, 2029
- Enrollment
- 240 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.